Clinical Trial Update: Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Pfizer-sponsored Phase 2 trial evaluating AG-013736 with cisplatin and gemcitabine in patients with squamous non-small cell lung cancer; the trial is completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• AG-013736
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Non-Small-Cell Lung (NSCLC) | Phase 2 | Status: COMPLETED | Results posted: 2013-01-03